ADVFN US – Market Content Editor
-

ORIC Pharmaceuticals Shares Rally 20% on Encouraging Cancer Drug Trial and Funding Update
Shares of ORIC Pharmaceuticals Inc. (NASDAQ:ORIC) jumped 20% following the release of early data from its ongoing Phase 1b clinical study evaluating ORIC-944 in combination with androgen receptor (AR) inhibitors for the treatment of metastatic castration-resistant prostate cancer (mCRPC). The interim results point to promising clinical efficacy and a manageable safety profile, potentially positioning ORIC-944…
-

Eton Pharmaceuticals Gains on FDA Green Light for Pediatric Drug KHINDIVI
Shares of Eton Pharmaceuticals Inc (NASDAQ:ETON) saw a 3.3% boost in premarket trading after the company announced U.S. Food and Drug Administration (FDA) approval of KHINDIVI™ (hydrocortisone) Oral Solution. The new treatment, developed for pediatric patients with adrenocortical insufficiency, represents a key achievement for Eton, which focuses on therapies for rare conditions. KHINDIVI stands out…
-

iPhone 16 Tops Global Smartphone Sales in Early 2025, Surpassing Rivals
A fresh report from Counterpoint Research highlights the most popular smartphones worldwide for the first quarter of 2025, with Apple (NASDAQ:AAPL) and Samsung (USOTC:SSNHZ) once again dominating the rankings. Apple’s latest flagship, the iPhone 16, claimed the top spot for the first time in a Q1 period since 2023. This comeback is credited to the…
-

Salesforce Raises Annual Outlook After Solid Q1; Announces $8B Informatica Acquisition
Salesforce Inc (NYSE:CRM) reported fiscal Q1 results that exceeded revenue and EPS expectations but slightly missed margin estimates. Adjusted EPS came in at $2.58 versus a $2.54 consensus, and revenue rose 8% YoY to $9.8 billion, beating the $9.75 billion forecast. However, operating margins were 32.3%, just below the expected 32.5%. CEO Marc Benioff highlighted…
-

Omada Health Launches IPO for 7.9 Million Shares at $18–$20 per Share
Omada Health announced the start of its initial public offering (IPO) roadshow, filing a registration statement with the U.S. Securities and Exchange Commission (SEC) to offer 7,900,000 shares of common stock. The company also plans to grant underwriters a 30-day option to purchase up to an additional 1,185,000 shares at the IPO price, less underwriting…
-

Hormel Foods Reports Q2 Earnings In-Line, Narrows Full-Year Outlook
Hormel Foods Corporation (NYSE:HRL) on Thursday reported second-quarter earnings that met analyst expectations, while revenue came in slightly below estimates. Hormel posted adjusted earnings per share of $0.35 for the quarter, in line with analyst estimates. Revenue totaled $2.9 billion, just under the consensus forecast of $2.92 billion. The company recorded organic net sales growth…
-

SentinelOne Stock Drops Sharply as Weak Guidance Overshadows In-Line Q1 Results
SentinelOne Inc (NYSE:S) reported fiscal first-quarter 2026 results that met expectations, but the company’s shares fell more than 14% in premarket trading Thursday following disappointing guidance. The cybersecurity firm posted adjusted earnings per share of $0.02, matching analyst estimates. Revenue grew 23% year-over-year to $229 million, slightly above the consensus of $228.34 million. Annualized recurring…
-

Foot Locker Falls Short of Q1 Expectations Amid Weaker Store Traffic
Foot Locker (NYSE:FL) reported first-quarter results that missed analyst forecasts, as softer traffic trends weighed on the retailer’s performance. The company posted a loss per share of $0.07 for Q1, falling short of the anticipated $0.01 loss per share. Revenue declined 4.6% year-over-year to $1.79 billion, below the projected $1.86 billion. Comparable store sales dropped…
-

Bath & Body Works Surpasses Q1 Earnings Expectations
Bath & Body Works, Inc. (NYSE:BBWI) delivered first-quarter earnings that beat analyst forecasts, with revenue hitting the upper end of its guidance, although the stock dipped about 1.3% following the report. For the quarter ending May 3, 2025, the home fragrance and personal care retailer posted adjusted earnings per share of $0.49, exceeding the consensus…
-

Kohl’s Shares Climb After Beating Q1 Estimates, Despite Cautious Guidance
Kohl’s Corporation (NYSE:KSS) saw its stock rise 3.7% in early trading Thursday after delivering first-quarter results that surpassed expectations, even as overall sales declined and forward guidance fell short of Wall Street projections. For the quarter ending May 3, 2025, the retailer reported a net loss of $0.13 per share—narrower than analysts’ forecast of a…